SCHEMBL24399705

SCHEMBL24399705

CNc1c(C)ccc2c(Cc3cccc(Cl)c3)nccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A2 P19784 1/20 0.40
▸ CSNK2B P67870 1/20 0.40
▸ TAAR1 Q96RJ0 1/20 0.38
▸ KDR P35968 2/20 0.38
▸ FLT1 P17948 1/20 0.38
▸ BRAF P15056 2/20 0.37
▸ LCK P06239 1/20 0.37
▸ TEK Q02763 1/20 0.37
▸ YTHDC1 Q96MU7 3/20 0.36
▸ YTHDF3 Q7Z739 2/20 0.36
▸ YTHDF1 Q9BYJ9 2/20 0.36
▸ YTHDF2 Q9Y5A9 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ SRC P12931 1/20 0.35
▸ PDE5A O76074 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ GAA P10253 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ ADRA1A P35348 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30401336 0.84 CSNK2A2 (0.41) CSNK2A2CSNK2BTAAR1KDRFLT1
SCHEMBL25374531 0.84 CSNK2A2 (0.41) CSNK2A2CSNK2BTAAR1KDRFLT1
SCHEMBL30402574 0.79 CSNK2A2 (0.40) CSNK2A2CSNK2BLMNAKDM4EHPGD
SCHEMBL25376248 0.79 CSNK2A2 (0.40) CSNK2A2CSNK2BLMNAKDM4EHPGD
SCHEMBL24399669 0.74 BRAF (0.71) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL30402640 0.67 FLT1 (0.38) KDRFLT1LMNAGAA
SCHEMBL24399590 0.67 FLT1 (0.38) KDRFLT1LMNAGAA
SCHEMBL24399619 0.66 KDR (0.46) KDRFLT1BRAFLCKTEK
SCHEMBL24399633 0.66 ROCK1 (0.45) TAAR1
SCHEMBL30402694 0.66 ROCK1 (0.45) TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022089219-A1 ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-05-05 — — WO disclosed
Send feedback